Abstract
Scleritis and peripheral ulcerative keratitis (PUK) can present as isolated conditions or as part of a systemic inflammatory or infectious disorder. Both are serious ocular conditions that can result in vision loss and require early diagnosis and treatment. Nearly two thirds of patients with non-infectious scleritis require systemic glucocorticoid therapy and one fourth need a glucocorticoid-sparing agent as well. Essentially all patients with non-infectious PUK require systemic glucocorticoids. A detailed clinical history, thorough physical examination, and thoughtful laboratory evaluations are important in the exclusion of underlying disorders and extraocular involvement.
| Original language | English |
|---|---|
| Pages (from-to) | 835-854 |
| Number of pages | 20 |
| Journal | Rheumatic Disease Clinics of North America |
| Volume | 33 |
| Issue number | 4 |
| DOIs | |
| State | Published - Nov 1 2007 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Rheumatology
Cite this
Scleritis and Peripheral Ulcerative Keratitis. / Galor, Anat; Thorne, Jennifer E.
In: Rheumatic Disease Clinics of North America, Vol. 33, No. 4, 01.11.2007, p. 835-854.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Scleritis and Peripheral Ulcerative Keratitis
AU - Galor, Anat
AU - Thorne, Jennifer E.
PY - 2007/11/1
Y1 - 2007/11/1
N2 - Scleritis and peripheral ulcerative keratitis (PUK) can present as isolated conditions or as part of a systemic inflammatory or infectious disorder. Both are serious ocular conditions that can result in vision loss and require early diagnosis and treatment. Nearly two thirds of patients with non-infectious scleritis require systemic glucocorticoid therapy and one fourth need a glucocorticoid-sparing agent as well. Essentially all patients with non-infectious PUK require systemic glucocorticoids. A detailed clinical history, thorough physical examination, and thoughtful laboratory evaluations are important in the exclusion of underlying disorders and extraocular involvement.
AB - Scleritis and peripheral ulcerative keratitis (PUK) can present as isolated conditions or as part of a systemic inflammatory or infectious disorder. Both are serious ocular conditions that can result in vision loss and require early diagnosis and treatment. Nearly two thirds of patients with non-infectious scleritis require systemic glucocorticoid therapy and one fourth need a glucocorticoid-sparing agent as well. Essentially all patients with non-infectious PUK require systemic glucocorticoids. A detailed clinical history, thorough physical examination, and thoughtful laboratory evaluations are important in the exclusion of underlying disorders and extraocular involvement.
UR - http://www.scopus.com/inward/record.url?scp=36248954411&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=36248954411&partnerID=8YFLogxK
U2 - 10.1016/j.rdc.2007.08.002
DO - 10.1016/j.rdc.2007.08.002
M3 - Article
C2 - 18037120
AN - SCOPUS:36248954411
VL - 33
SP - 835
EP - 854
JO - Rheumatic Disease Clinics of North America
JF - Rheumatic Disease Clinics of North America
SN - 0889-857X
IS - 4
ER -